1. Academic Validation
  2. Synthesis, cytotoxicity and DNA binding of oxoazabenzo[de]anthracenes derivatives in colon cancer Caco-2 cells

Synthesis, cytotoxicity and DNA binding of oxoazabenzo[de]anthracenes derivatives in colon cancer Caco-2 cells

  • Eur J Med Chem. 2013 Nov:69:754-61. doi: 10.1016/j.ejmech.2013.08.038.
Alberto Di Salvo 1 Pauline Dugois Delphine Tandeo Marie Peltekian Paul Kong Thoo Lin
Affiliations

Affiliation

  • 1 Institute for Health & Welfare Research, School of Pharmacy & Life Sciences, Robert Gordon University, Riverside East, Garthdee Road, Aberdeen AB10 7GJ, Scotland, UK. Electronic address: a.di-salvo@rgu.ac.uk.
Abstract

New oxoazabenzo[de]anthracenes derivatives were synthesised and characterised. Their interactions with calf thymus DNA were studied by UV spectrophotometric analysis and a competitive ethidium bromide displacement assay. Cytotoxicity was determined by MTT assay, against colon adenocarcinoma (Caco-2 cells). Among all the oxoazabenzo[de]anthracenes derivatives reported herein only the piperidino derivative exhibited strong DNA binding properties and cytotoxic activity with IC₅₀ values in the range of 16 ± 1.5 μM (72-h treatment). In addition, the piperidino derivative did not directly inhibit Topoisomerase I and Topoisomerase II Enzymes. The results confirm that the presence of the oxoazabenzo[de]anthracenes together with the piperidino functionality is crucial in exerting DNA binding and cytotoxic properties, hence demonstrating promise as a chemical scaffold for further development of new Anticancer agents.

Keywords

Anthraquinone derivatives; Anticancer; Cytotoxicity; DNA-binding; Synthesis.

Figures